Walgreens, KKR complete $1.4 billion acquisition of PharMerica

A joint venture between KKR& Co. L.P. and Walgreens Boots Alliance Inc. has completed its acquisition of Louisville-based institutional pharmacy provider PharMerica Corp. in a $1.4 billion deal. PharMerica (NYSE: PMC) shareholders will receive $29.25 per share for their stock in the company, which will cease trading on the New York Stock Exchange tomorrow. PharMerica announced the merger in August and said the deal would be completed in early 2018. The all-cash deal includes the assumpti on of…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news